For the complete documentation index, see llms.txt.Skip to main content
Topic
News & analysis tagged Ibogaine — diplomacy, politics, and global affairs coverage from Model Diplomat.

Trump's Executive Order 14401 directs the FDA to fast-track ibogaine, a Schedule I drug with no completed trials, raising safety and regulatory concerns.
2026-04-18Trump's April 2026 executive order accelerates FDA approval for psilocybin, signaling a shift in psychedelic drug policy.
2026-04-18
Trump's Executive Order 14401 on ibogaine prioritizes psilocybin over the plant, benefiting veterans' lobby and Compass Pathways.
2026-04-18
Trump's executive order fast-tracks federal review of psychedelics like ibogaine, aiming to expand PTSD and addiction treatment options for U.S. veterans.
2026-04-18